U.S. Pharmaceutical Robots Market Size & Outlook
U.S. pharmaceutical robots market, 2018-2030 (US$M)
Related Markets
U.S. pharmaceutical robots market highlights
- The U.S. pharmaceutical robots market generated a revenue of USD 17.3 million in 2023 and is expected to reach USD 36.0 million by 2030.
- The U.S. market is expected to grow at a CAGR of 11% from 2024 to 2030.
- In terms of segment, traditional robots was the largest revenue generating type in 2023.
- Collaborative Robots is the most lucrative type segment registering the fastest growth during the forecast period.
Pharmaceutical robots market data book summary
| Market revenue in 2023 | USD 17.3 million |
| Market revenue in 2030 | USD 36.0 million |
| Growth rate | 11% (CAGR from 2023 to 2030) |
| Largest segment | Traditional robots |
| Fastest growing segment | Collaborative Robots |
| Historical data | 2016 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Traditional Robots, Collaborative Robots |
| Key market players worldwide | ABB Ltd, Teradyne Inc, Kawasaki Heavy Industries Ltd, YASKAWA Electric Corp, Fanuc Corp, Marchesini Group, Seiko Epson Corp, Denso Corp, Mitsubishi Electric Corp, KUKA Robotics |
Other key industry trends
- In terms of revenue, U.S. accounted for 8.7% of the global pharmaceutical robots market in 2023.
- Country-wise, China is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. pharmaceutical robots market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 7.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pharmaceutical Robots Market Scope
Pharmaceutical Robots Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. pharmaceutical robots market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical robots market will help companies and investors design strategic landscapes.
Traditional robots was the largest segment with a revenue share of 63.01% in 2024. Horizon Databook has segmented the U.S. pharmaceutical robots market based on traditional robots, collaborative robots covering the revenue growth of each sub-segment from 2018 to 2030.
According to the data published by CNBC in June 2020, cumulative unemployment rate in the U.S. decreased from 14.7% in April 2020 to 13.3% in May 2020, whereas 30% of manufacturers stated that they are seeking to hire new employees during COVID-19 pandemic as the overall employment rate in manufacturing sector is facing a sharp contraction, declining at a rate of 19.1% from January 2020 to April 2020.
This is anticipated to drive the demand for pharmaceutical robots to overcome labor shortage and expand automation in the country. In addition, rise in the number of robot installations coupled with various benefits associated with automation, including efficiency, reducing training overhead, saving workers from repetitive tasks or hazardous environments, increasing repeatability & reproducibility, is further boosting the market growth in the country.
Reasons to subscribe to U.S. pharmaceutical robots market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. pharmaceutical robots market databook
-
Our clientele includes a mix of pharmaceutical robots market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. pharmaceutical robots market , including forecasts for subscribers. This country databook contains high-level insights into U.S. pharmaceutical robots market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. pharmaceutical robots market size, by type, 2016-2030 (US$M)
U.S. Pharmaceutical Robots Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
